Hyperoxaluria

Status

Open

Fund Type

Copay
Premium (Medicare Part B only)

Maximum Award Level

$8,000

Pharmacy Card Fund

Yes

Minimum Copay
Reimbursement Amount

Minimum Copay Reimbursement Amount

We encourage you to please use your HealthWell pharmacy card for any applicable charges as possible.

None

Minimum Premium
Reimbursement Amount

Minimum Premium Reimbursement Amount

We encourage you to please submit monthly reimbursement claims (even if your premium is paid on a bi-weekly basis).

None

Household Income Limit

500% of the Federal Poverty Level
(adjusted for household size and high
cost of living areas)

Fund Alerts

Sign up for email or text/call alerts to receive instant notifications.

Treatments Covered

  • Chlorothiazide
  • Chlorthalidone
  • Chlorthalidone Avpak
  • Dibasic/na Phos
  • Diuril
  • Hydrochlorothiazide
  • Indapamide
  • K Phos Monobasic
  • K Phos/na Phos
  • K-phos Neutral
  • K-phos No. 2
  • K-phos Original
  • Methyclothiazide
  • Metolazone
  • Monobasic
  • Oxlumo
  • Phos-nak
  • Phospha 250 Neutral
  • Potassium Citrate
  • Potassium Citrate Monohydrate
  • Pyridoxine Hcl
  • Rivfloza
  • Urocit-k
  • Urocit-k 10
  • Urocit-k 5
  • Vitamin B6 (non Otc)

Fund Definition

Assistance with the prescription drugs and biologics used in the treatment and management of Hyperoxaluria.

Grant Utilization

HealthWell estimates that patients use an average of $2,900 during their 12-month grant period for this disease area.

Do I Qualify?

HealthWell bases eligibility on an individual’s medical, financial and insurance situation. To qualify for HealthWell’s assistance, applicants must meet the following eligibility requirements:

  • Please make sure that HealthWell currently has a fund for your diagnosis/indication and that your medication is covered under that fund by visiting our Diseases and Medications listing. If we do not have a fund that currently covers your diagnosis, please check back as we frequently open and reopen programs as funding becomes available. The Foundation is able to help patients receiving treatment for indications for which we currently have an open fund. We can only assist with medications that have been prescribed to treat the disease/covered diagnosis. You will be asked to provide the Foundation with the patient’s diagnosis, which must be verified by a physician, nurse practitioner, or physician assistant’s signature. The patient must receive treatment in the United States.

  • To qualify for copayment assistance from HealthWell, you must have some form of health insurance (private insurance, Medicare, Medicaid, TriCare, etc.) that covers part of the cost of your treatment. Please note that in order to qualify for premium assistance through this fund, you must have Medicare Part B. The Foundation will refer patients without prescription insurance to other programs, such as manufacturer patient assistance programs.

  • HealthWell assists individuals with incomes up to 300-500% of the Federal Poverty Level. The Foundation also considers the number in a household and cost of living in a particular city or state. If you believe you qualify for assistance, you may begin the application process here.

  • If you are receiving treatment in the U.S. and have met the eligibility criteria as listed, you are ready to apply! Please note that you will be asked to provide a Social Security Number in order to create a grant. This information is gathered to eliminate duplicate applications and is kept secure and confidential.

About Hyperoxaluria

According to the Oxalosis and Hyperoxaluria Foundation, hyperoxaluria occurs when a person’s urine contains too much oxalate, a natural chemical in the body which is also found in certain types of food. High levels of oxalate are toxic because oxalate cannot be broken down by the human body and accumulates in the kidneys. Hyperoxaluria can be caused by a genetic disorder, eating too many oxalate-rich foods or an intestinal disease.

There are two forms of hyperoxaluria:

  • Primary hyperoxaluria (PH) is a family of ultra-rare, life-threatening genetic disorders that cause complications in the kidneys. There are 3 types of PH: type 1 (PH1), type 2 (PH2), and type 3 (PH3), each resulting from a mutation in one of three different genes. These genetic mutations all cause enzyme deficiencies that cause the overproduction of oxalate.
  • Enteric hyperoxaluria (EH) is a common occurrence in the setting of fat malabsorption, usually due to intestinal resection or intestinal bypass surgery. Enhanced intestinal absorption of dietary oxalate leads to elevated oxalate excretion.

Abnormal production and accumulation of oxalate can lead to recurrent kidney stones, nephrocalcinosis and chronic kidney disease. Over time, the buildup of oxalate in the kidneys can lead to kidney failure. As kidney function worsens, the kidneys are no longer able to eliminate oxalate and oxalate crystals form throughout the body. The damage happens at different rates in different people and it can be permanent, this is called oxalosis. The deposits can occur in multiple organs in the body, including the eyes, bones, skin and heart. In some cases, hyperoxaluria can result in the need for kidney transplantation or a dual liver-kidney transplant. Early diagnosis and treatment are important to the long-term health of the kidneys. Source: Oxalosis and Hyperoxaluria Foundation

Additional Educational Resources

You may also visit our Resource List to view other copayment organizations that may provide assistance.